KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Invested Capital: 2009-2025

Historic Invested Capital for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $86.5 billion.

  • Thermo Fisher Scientific's Invested Capital rose 2.88% to $86.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $86.5 billion, marking a year-over-year increase of 2.88%. This contributed to the annual value of $80.7 billion for FY2024, which is 0.99% down from last year.
  • Thermo Fisher Scientific's Invested Capital amounted to $86.5 billion in Q3 2025, which was up 1.13% from $85.5 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Invested Capital ranged from a high of $86.5 billion in Q3 2025 and a low of $53.7 billion during Q2 2021.
  • Over the past 3 years, Thermo Fisher Scientific's median Invested Capital value was $81.5 billion (recorded in 2023), while the average stood at $81.9 billion.
  • In the last 5 years, Thermo Fisher Scientific's Invested Capital spiked by 37.94% in 2022 and then decreased by 0.99% in 2024.
  • Thermo Fisher Scientific's Invested Capital (Quarterly) stood at $75.5 billion in 2021, then rose by 3.69% to $78.3 billion in 2022, then climbed by 4.03% to $81.5 billion in 2023, then declined by 0.99% to $80.7 billion in 2024, then grew by 2.88% to $86.5 billion in 2025.
  • Its last three reported values are $86.5 billion in Q3 2025, $85.5 billion for Q2 2025, and $83.4 billion during Q1 2025.